Brown & Brown stock steadies after strong Q2 2026 revenue and slight EPS miss
Published on 08/28/2026 at 10:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Brown & Brown, Inc. (US1156371007) delivered a robust top-line performance in the second quarter of 2026, with revenue climbing to $1.68 billion and growing 30.4 percent compared with Q2 2025, while adjusted earnings per share of $1.07 landed modestly below market expectations in late August 2026. Per a recent earnings overview dated August 27, 2026, the shares have been trading in the low $70s after the report, only a few dollars below the consensus target price of $76.80.
Q2 2026 growth and earnings mix
Per the Q2 2026 results summary, Brown & Brown lifted its revenue to $1.68 billion in the quarter ended June 30, 2026, up from the prior-year period by 30.4 percent, underscoring strong growth momentum across its insurance brokerage activities. The same overview highlights that adjusted earnings per share reached $1.07 in Q2 2026, coming in 0.9 percent below the analyst consensus, which points to a quarter where revenue outpaced expectations but profitability lagged slightly behind forecasts. The combination of double-digit percentage revenue growth and a small shortfall on EPS indicates that investment and cost dynamics mattered for margins even as top-line trends remained favorable.
In the broader valuation context, the market data in the same report shows the shares trading around $73 as of August 27, 2026, compared with a consensus price target of $76.80, implying a discount of around 5 percent to where analysts see fair value for Brown & Brown stock. That gap between the share price range of $72.79 to $73.35 and the $76.80 target underlines that the strong revenue story has not yet fully translated into closing the valuation distance that some institutional research assigns to the stock. For investors, this creates a narrative where the top-line beat is visible but the modest EPS miss and broader sector considerations keep the shares a few dollars below target levels.
Share price range after the Q2 release
The same-day trading ranges give additional color on how the market has processed the Q2 2026 numbers. According to the Q2 follow-up coverage, Brown & Brown shares were quoted between $72.79 and $73.35 in the days leading up to August 27, 2026, with a representative price level of $73.35 appearing in comparative tables of listed insurance brokers after the earnings announcement. Another institutional data snapshot for the same period cites $72.79 as an opening quote, illustrating that intraday trading activity has largely been confined to a narrow band in the low $70s even with the new information in the market.
That relatively tight price corridor contrasts with the larger 30.4 percent year-over-year revenue expansion and hints that investors are calibrating their response, weighing the strong growth outcome against the modest 0.9 percent EPS shortfall relative to consensus. With the average analyst target at $76.80 and the shares sitting around $73 as of August 27, 2026, the gap is neither a deep discount nor a full pricing-in of the growth trajectory. Instead, Brown & Brown stock appears to be consolidating slightly below target levels while the market digests how sustainable the Q2 2026 revenue pace is and how quickly margins can catch up.
Analyst consensus and valuation context
The latest consensus data compiled in the same August 27, 2026 coverage indicates that Brown & Brown currently carries an average rating of "Hold" and a blended analyst price objective of $76.80 for the stock. With the reported trading levels close to $73 around August 27, 2026, the implied upside to consensus sits at approximately 5 percent, providing a modest potential gain if the stock were to align fully with the target. That valuation spread is consistent with a view that appreciates Brown & Brown's strong revenue momentum but remains cautious until profitability metrics show clearer alignment with forecasted levels.
From a relative standpoint, the 30.4 percent year-over-year revenue increase in Q2 2026 stands out among insurance brokers, given that such growth rates are typically lower in more mature brokerage markets. The modest 0.9 percent EPS undershoot versus consensus, however, acts as a counterweight, suggesting that incremental revenue has not yet translated one-to-one into higher adjusted earnings per share. For Brown & Brown stock, the interplay of rapid revenue growth, a slight earnings miss, and a small discount to consensus price targets frames the current valuation story as one that depends on the company demonstrating improved margin leverage in subsequent quarters.
Representative insurance brokerage services
Brown & Brown is known for a wide portfolio of insurance brokerage and risk management services, ranging from commercial property and casualty placement for corporate clients to employee benefits advisory for mid-sized businesses. Within that portfolio, one representative offering is its program business and wholesale brokerage solutions, which structure insurance coverage for specific industry niches such as transportation, hospitality, or construction. These arrangements often involve designing tailored programs that bundle multiple coverage types into a single framework, enabling clients to address liability, property, and specialty risks through one coordinated solution.
In practice, program and wholesale brokerage work requires deep expertise in underwriting criteria, regulatory demands, and the risk characteristics of the sectors served. Brown & Brown aggregates coverage from multiple carriers, negotiates terms that reflect the claims history and risk exposure of the target segment, and then delivers the assembled program to agents and insureds through a distribution network. For clients, the value lies in the broker's ability to match complex needs with appropriate coverage structures, while for Brown & Brown the business contributes fee and commission income that can scale with the number of insureds and the breadth of risks covered.
Stock level and market context
Based on the detailed trading data referenced in the August 27, 2026 coverage, Brown & Brown stock was quoted in a band between $72.79 and $73.35 in the days around August 27, 2026, with course levels around $73 prevailing as investors reacted to the Q2 2026 report. This price zone, sitting only a few dollars below the $76.80 consensus target, encapsulates a market stance that recognizes the 30.4 percent year-over-year revenue acceleration but has yet to fully rerate the shares consistent with that growth. As of the latest completed trading session before August 28, 2026, Brown & Brown stock therefore remains anchored in the low $70s, leaving a moderate valuation gap that future earnings performance will either narrow or widen depending on how margins and cash flows evolve.
Read more
More on Brown & Brown stock and its recent Q2 2026 results can be found via recent detailed coverage from late August 2026, which discusses the $1.68 billion revenue figure, the 30.4 percent growth rate versus Q2 2025, the $1.07 adjusted EPS outcome, and the trading range between $72.79 and $73.35 ahead of August 27, 2026.
Fact box
Company: Brown & Brown, Inc.
ISIN: US1156371007
Ticker: BRO
Exchange: NYSE
Market cap: value in billions of USD, as of late August 2026, based on the prevailing share price near $73 and the company’s share count as cited in recent market data.
Sector / Industry: Insurance brokerage and risk management services
Index membership: S&P 500
